📄 Redirect examination of Renee Montgomery — Wednesday, May 24, 1995
Address:
C:\DEPT103\CRIMINAL\1995\MAY\24\REDIRECT-EXAMINATION-OF-RENEE-.DOC
TRIAL
▲ Day 81 of 167

Redirect examination of Renee Montgomery

Witness: Renee Montgomery
Examiner: Rockne Harmon
Called by: Prosecution • Date: Wednesday, May 24, 1995 • Utterances: 480
Redirect examination of DNA analyst Renee Montgomery, where prosecutor Harmon rehabilitated her testimony after Blasier's cross-examination by addressing the reliability of computer scan photos versus original gels, documenting scientific literature support for PCR inhibition and cross-hybridization, and clarifying glove stain locations. Blasier then recrossed, effectively establishing that cross-hybridization conditions described in the manufacturer's manual did not match the low-DNA mixed samples in this case, and that OJ Simpson was excluded from all glove stains except the wrist area. The examination ended with a light moment as Harmon asked whether amplicons could 'turn left' if they were 'willful.'
1 (The following proceedings were held in open court, in the presence of the jury:)
2 THE COURT:

All right. Thank you, ladies and gentlemen. Please be seated. Miss Montgomery, would you come forward, please.

Renee Montgomery, the witness on the stand at the time of the evening adjournment, resumed the stand and testified further as follows:

3 THE COURT:

All right. Good morning, Miss Montgomery.

4 MS. MONTGOMERY:

Good morning.

5 THE COURT:

Miss Montgomery, you are reminded that you are still under oath. And Mr. Harmon, you may commence your redirect examination.

6 MR. HARMON:

Thank you, your Honor. Good morning, ladies and gentlemen.

THE JURY: Good morning.

REDIRECT EXAMINATION BY MR. HARMON

7 MR. HARMON:

Miss Montgomery, Mr. Blasier asked you some questions about how recently your laboratory implemented D1S80 yesterday. Do you recall that?

8 MS. MONTGOMERY:

Yes, I do.

9 MR. HARMON:

And he also asked you a question about cellmark and I believe you said cellmark is not using the D1S80 marker. Do you recall that?

10 MS. MONTGOMERY:

That's correct.

11 MR. HARMON:

Are there a number of labs which are using the D1S80 marker currently?

12 MS. MONTGOMERY:

Yes. There are, umm, both private and public laboratories that are using the D1S80 marker. Some of the laboratories are the Minnesota State laboratory, Dr. Ed Blake's laboratory, which is FSA. It is in northern California. The Orange County Crime Laboratory is using D1S80. AFIP, which is the Armed Forces Institute of Pathology, is using D1S80. Did I state Minnesota crime lab.

13 MR. HARMON:

Yes?

14 MS. MONTGOMERY:

Laboratory?

15 MR. HARMON:

And others?

16 MS. MONTGOMERY:

Oh, yes, and there are other laboratories that are using it.

17 MR. HARMON:

Now, yesterday with Mr. Blasier's examination of you, you realize that many of the exhibits that were projected up there are computer scan photos that were taken by Dr. Blake, do you not?

18 MS. MONTGOMERY:

Yes.

19 MR. HARMON:

Do those photos accurately represent the data which is on the original gel from which you produced your results?

20 MS. MONTGOMERY:

No. As I stated yesterday, it is best to see the actual duplicate copy, the blue copy, to see what bands are present.

21 MR. HARMON:

And using scan photos projected on the elmo up on this screen to show or to attempt to demonstrate that something is not there, do you feel that is a scientifically reliable way to determine whether something is on the original gel?

22 THE COURT:

Excuse me, counsel. That misstates the application.

23 MR. HARMON:

Pardon me, your Honor?

24 THE COURT:

That misstates. They were computer--they are coming--computer-generated photographs coming off a hard drive; not from the elmo.

25 (Discussion held off the record between the Deputy District Attorneys.)
26 MR. HARMON:

I'm sorry, your Honor. Our computer expert has--

27 THE COURT:

Whispered in your ear.

28 MR. HARMON:

--straightened me out on that.

29 MR. BLASIER:

I also object. It is argumentative.

30 THE COURT:

Rephrase the question.

31 MR. HARMON:

Do those--those computer scanned photos which were projected up on the screen, do they in any way accurately reflect what was not--what you saw on the original gel when they are used to demonstrate that something is not on the original gel?

32 MS. MONTGOMERY:

Well, no. You lose some of the sensitivity. It is good just for a guide to give you some bearing on what is on the gel, but you actually need to see the gel yourself and to view that gel.

33 MR. HARMON:

Okay. Mr. Blasier also put up on the screen analytical gel 184 which--where there was--remember the discussion about what you described as an artifact in between lanes for the other substrate control and an extraction blank? Do you recall that?

34 MS. MONTGOMERY:

Yes.

35 MR. HARMON:

Okay. And just to reflect back, the purpose of a substrate control is what?

36 MS. MONTGOMERY:

It is to show you what the substrate around the stain in question is--what is occurring with that stain, so if there is any background, you need to be able to detect that background.

37 MR. HARMON:

And is it important in that regard to look at the actual stain which is adjacent to the substrate control?

38 MS. MONTGOMERY:

Yes, it is.

39 MR. HARMON:

Now, let's assume--I know you say that is an artifact. I want you to imagine or assume that that was not an artifact, that that was really a band on a g184, even though it is between lanes. Even though you have described it, it is not a band, I want you to imagine that it is a band. Okay?

40 MS. MONTGOMERY:

Okay.

41 MR. HARMON:

Imagining that really was a band on the other substrate control, would it be important for you to compare this imaginary band with the actual stain for 50 to see if that imaginary band appears in the stain?

42 MS. MONTGOMERY:

Well, yes, it would. If--let's hypothetically say that--

43 MR. BLASIER:

Objection, objection. No foundation to say that you can see it in a stain.

44 THE COURT:

Sustained. Rephrase the question.

45 MR. HARMON:

Would it be important for you, imagining that that really was a band, even though that is not your opinion, to look at the typing results for the substrate control to see if that imaginary band appears there?

46 MR. BLASIER:

Objection, vague as to what typing results.

47 THE COURT:

Overruled.

48 MS. MONTGOMERY:

Yes. One would want to look at the substrate control, and if banding did occur in the substrate control or if any DNA was detected there, then you would want to compare that to your evidence sample.

49 MR. HARMON:

Okay. And do you recall what your typing results were for stain no. 50, one of those Bundy walk stains?

50 MS. MONTGOMERY:

I will have to look at the report and my notes.

51 (Brief pause.)
52 MR. HARMON:

While you are doing that, this imaginary band that you have already described was not there, where did it line up with respect to the ladder?

53 MR. BLASIER:

Your Honor, object to the term "Imaginary" as being argumentative.

54 THE COURT:

Sustained. Rephrase the question.

55 MR. HARMON:

Imagining that that really was a band--

56 MS. MONTGOMERY:

Yes.

57 MR. HARMON:

--which I'm forcing you to do in this question, where did that band that I have asked you to imagine line up with?

58 MS. MONTGOMERY:

Well, as--when Mr. Blasier was--excuse me--asking me we were--we saw that it was right in between the--I believe it was the 17, but let me look at my notes again to be sure of that.

59 (Brief pause.)
60 MS. MONTGOMERY:

Mr. Harmon, what gel number was it, analytical gel number?

61 THE COURT:

184.

62 MR. HARMON:

184 is what I have written down.

63 MS. MONTGOMERY:

Thank you.

64 (Brief pause.)
65 MS. MONTGOMERY:

The evidence sample, DNA--I'm sorry, DNA 8, LAPD no. 50 from the Bundy crime scene, came back a 24, 25.

66 MR. HARMON:

Okay. Could we project 275-C up, your Honor.

67 (Brief pause.)
68 MR. HARMON:

Okay. Now, if you recall exhibit 275-C--do you want to take a look at it?

69 MR. BLASIER:

Your Honor, I'm going to object. May we approach?

70 THE COURT:

Overruled.

71 MR. HARMON:

You can turn that off.

72 MR. HARMON:

The bands in that stain were a 24, 25; is that true?

73 MS. MONTGOMERY:

That's correct.

74 MR. HARMON:

And nothing appeared in the area of the band that I have asked you to imagine appearing in 50 control; is that true?

75 MS. MONTGOMERY:

That's correct.

76 MR. HARMON:

And even if that band that I have asked you to imagine was on the other control, the fact that you see nothing on the other stain, what is the significance of that? And I'm asking you to imagine something that is contrary to your scientific opinion.

77 MS. MONTGOMERY:

Well, the only banding pattern that was seen on the evidence sample that relates to that substrate control was a 24 band and a 25 band. There are no bands seen in any other region of that gel.

78 MR. HARMON:

Okay. Let's move to the proficiency tests that were shown up on the screen by Mr. Blasier. Did you know that the correct answer to the quality control sample on that proficiency test was a 1.1, 3?

79 MS. MONTGOMERY:

No, I did not. These are blind--or they are unknown to me. The results are unknown to me when I'm doing the analysis.

80 MR. HARMON:

Did you make up the explanation of cross-hybridization for describing in your notes on the result sheet what you saw in that QC result?

81 MS. MONTGOMERY:

No. Cross-hybridization is documented in a lot of the literature.

82 MR. HARMON:

Is it listed in the manufacturer's user guide on page 6-5?

83 MS. MONTGOMERY:

Yes. It is noted in the Roche user's guide.

84 MR. HARMON:

Okay. Is it also mentioned in Dr. Blake's case work article, "The phenomenon of cross-hybridization" on page 704?

85 MS. MONTGOMERY:

Dr. Blake does mention cross-hybridization in his 1992 case work paper. As far as the exact page, you would have to show me the document.

86 MR. HARMON:

Okay. And moving to the test sample, and in your proficiency tests, when you wrote down what your opinion was when you saw the data, did you know that the correct answer was 1.2, 3?

87 MS. MONTGOMERY:

No, I did not.

88 MR. HARMON:

Mr. Blasier put up the gel where the three reference samples were initially run and you described that you were unable to type Mr. Simpson. Do you recall that yesterday?

89 MS. MONTGOMERY:

Yes. Mr. Simpson's sample gave no results on the first amplification.

90 MR. HARMON:

Okay. And your explanation for that was PCR inhibition. Do you recall that?

91 MS. MONTGOMERY:

Correct.

92 MR. HARMON:

Did you make up the explanation inhibition to explain that?

93 MS. MONTGOMERY:

No, I did not.

94 MR. HARMON:

Is the subject of inhibition, PCR inhibition mentioned, in the user guide by the manufacturer of these kits?

95 MS. MONTGOMERY:

Yes, it is.

96 MR. HARMON:

Is it also mentioned in Dr. Blake's case work article on page 719?

97 MS. MONTGOMERY:

Yes. Dr. Blake does mention it. As far as the exact page, I would have to look at the document.

98 MR. HARMON:

Is it also mentioned in the chapter 17 that was authored by Dr. Blake and Cecelia von Beroldinger on page 214, the subject of PCR inhibition?

99 MS. MONTGOMERY:

Chapter 17 of the PCR technology book?

100 MR. HARMON:

Yes.

101 MS. MONTGOMERY:

Yes. It is addressed--inhibition is addressed in that article also.

102 MR. HARMON:

Is it also addressed in the analytical chemical article that we have discussed authored by Dr. Blake and Becky Reynolds from Roche?

103 MS. MONTGOMERY:

The article by Dr. Blake and Dr. Reynolds does mention inhibition also.

104 MR. HARMON:

And is it also discussed in a chapter in the book, the Saferstein book the way we have described it, the authors of which are Dr. Blake and Dr. Sensabaugh, the subject of PCR inhibition?

105 MS. MONTGOMERY:

Well, Saferstein has three books out, and in the third edition there is a chapter devoted--the chapter I believe you are referring to is devoted to PCR and there is mention of inhibition in that chapter.

106 MR. HARMON:

And is there also an article by Dr. Blake--

107 THE COURT:

Excuse me, counsel. Aren't we getting cumulative at this point?

108 MR. HARMON:

It is my last article, your Honor.

109 THE COURT:

All right. Last one.

110 MR. HARMON:

Is the phenomenon documented by Dr. Blake and Mr. Haguchi or Dr. Haguchi, who is also from Roche, in a 1989 symposium paper that was published in the FBI symposium? Do you want to take a look at that one?

111 MS. MONTGOMERY:

Yes. Could I take a look at that?

112 (Brief pause.)
113 MR. HARMON:

The name of the article is "PCR inhibition in bloodstains."

114 (Brief pause.)
115 MS. MONTGOMERY:

Yes, I recognize this article and it does discuss inhibition in this article, also.

116 MR. HARMON:

And when faced with the prospect of PCR inhibition or the--or strike that. Do all of these articles also discuss what you do when you think there is PCR inhibition?

117 MS. MONTGOMERY:

Yes. If inhibition occurs with the sample, and by inhibition you don't get any typing results, no product is obtained from that sample, analysis should be reconducted to try to get a result from that sample and then it could be reconducted by either diluting the sample--by diluting the sample out and then reamplifying it.

118 MR. HARMON:

Okay. Okay. Is that what you did?

119 MS. MONTGOMERY:

Yes, I did.

120 MR. HARMON:

And in your opinion is that what any responsible forensic scientist would do?

121 MS. MONTGOMERY:

Yes.

122 MR. HARMON:

Now, did you see--remember Mr. Blasier showed those graphics, one about the glove and they purported to show the locations of stains where the 25 alleles were found. Do you recall that yesterday?

123 MS. MONTGOMERY:

Yes, I do.

124 MR. HARMON:

Could we put that up on the screen, your Honor.

125 (Discussion held off the record between the Deputy District Attorneys.)
126 THE COURT:

All right. This is Defense exhibit--

127 MR. FAIRTLOUGH:

1173-C.

128 THE COURT:

All right.

129 MR. HARMON:

Okay. Have you had a chance to look at that?

130 MS. MONTGOMERY:

Yes.

131 MR. HARMON:

And are you familiar with the sampling of the glove and the relationship of the stains that were typed by you and Mr. Sims that produced the--that detected the 25 allele?

132 MS. MONTGOMERY:

Yes, I have reviewed some photographs.

133 MR. HARMON:

Is that slide misleading in terms of the location of the stains?

134 MR. BLASIER:

Objection, argumentative.

135 THE COURT:

Sustained. Rephrase the question.

136 MR. HARMON:

How misleading is that slide with respect to showing where those stains actually are?

137 THE COURT:

Counsel, counsel, rephrase the question.

138 MR. HARMON:

Does that slide accurately reflect the location of the stains which produced the 25 allele?

139 MS. MONTGOMERY:

Well, I think the best depiction would be to see the actual photograph, to see--

140 MR. BLASIER:

Object, nonresponsive.

141 THE COURT:

Overruled.

142 MR. HARMON:

Why is that?

143 MS. MONTGOMERY:

Because that is the actual documentation of this item.

144 MR. HARMON:

Okay. Would you like to do that, please. We will put that board up. Just stay right where you are.

145 (Brief pause.)
146 (Discussion held off the record between the Deputy District Attorneys.)
147 MR. HARMON:

272-A and B, your Honor, are the exhibit numbers.

148 (Brief pause.)
149 MR. HARMON:

Miss Montgomery, why don't you look at the slide again. From looking at that can you tell whether that is a right-hand glove or a left-hand glove?

150 MS. MONTGOMERY:

I believe it could be either glove, depending on the orientation of the hand.

151 MR. HARMON:

Okay. Would you look at 272-B, the photo board, and if you could take the pointer and show us where those stains really are on that right-hand glove, no. 9, from Bundy--from Rockingham.

152 MR. BLASIER:

Objection, argumentative.

153 THE COURT:

Sustained. Rephrase the question. And Mr. Harmon, how about if we take that board and put it on the main easel. You can put it on top of the results board.

154 MR. HARMON:

Okay.

155 THE COURT:

Because it is--the height of that exhibit in that location--

156 MR. HARMON:

I just wanted to have them both together. That is fine.

157 THE COURT:

All right.

158 (Brief pause.)
159 THE COURT:

All right. Rephrase the question, please.

160 MR. HARMON:

Okay. Would you point out to the jury where the stains which produced the 25 allele are?

161 MS. MONTGOMERY:

Okay.

162 MR. HARMON:

Or where they were?

163 MS. MONTGOMERY:

Once again, just by looking at my notes to get the exact item numbers, a 25 allele was detected on G10 and there was a 25 on--

164 MR. HARMON:

Okay. Just, you know, because those are inside out gloves, two of them, and one is right side out, could you make it real clear where--what surface that is on and where it is. Just describe it in words, please.

165 MS. MONTGOMERY:

Okay. G10 is the inside surface near this wrist notch and the results of G10 were a 25 allele and a weaker 25 allele.

166 MR. HARMON:

Okay. Next stain.

167 MS. MONTGOMERY:

There was also a 25 allele detected at G11 and G11 is the outside palmer surface of the glove, (Indicating). And what was detected here was a 24 allele and a weaker 25 and 18 alleles.

168 MR. HARMON:

Okay.

169 MS. MONTGOMERY:

On G13, (Indicating), which is also the outside surface of the glove, there was--near the notch area, there was a 24 allele detected and also weaker 25 and 18 alleles detected in this region, (Indicating).

170 MR. HARMON:

Okay. Thanks, Miss Montgomery. You can go back and have your seat.

171 (Witness complies.)
172 MR. HARMON:

Mr. Blasier asked you about a problem you had with one of the glove gels. Do you recall that, with the ladder leaking?

173 MS. MONTGOMERY:

Yes, I do.

174 MR. HARMON:

And your solution to that was to rerun the test; is that right?

175 MS. MONTGOMERY:

Yes. Anytime I am not confident with the result or if there is any question in the results, I will do a reanalysis on those samples.

176 MR. HARMON:

Okay. In fact, did you get the same answers when you reran that gel that you did on the gel where the ladder leaked into the lane?

177 MS. MONTGOMERY:

Yes. For the evidence samples and the controls I obtained the same results.

178 MR. HARMON:

And is that what a responsible forensic scientist would do when faced with that problem?

179 MS. MONTGOMERY:

Well, I think any individual, when there is a question, needs to do reanalysis on samples.

180 MR. HARMON:

And Mr. Blasier projected a G295 up there, the rear gate gel. Do you recall that yesterday?

181 MS. MONTGOMERY:

Yes, I do.

182 MR. HARMON:

Okay. And in your opinion you described what was on there that he directed your attention to as not a problem; is that true?

183 MS. MONTGOMERY:

Could you state specifically what the problem he addressed on that gel was?

184 THE COURT:

Miss Montgomery, why don't you pull the microphone closer.

185 (Witness complies.)
186 MR. HARMON:

Sure.

187 (Brief pause.)
188 MR. HARMON:

I don't really recall. We heard about a lot of problems yesterday.

189 MR. HARMON:

Do you recall that there was a problem, perhaps a band, a line of bands that went all the way across the gel or a line of shadows that went across the gel?

190 MS. MONTGOMERY:

Well, I will look at that gel and see if that is the one that had the silver smearing across the bottom region.

191 (Brief pause.)
192 MS. MONTGOMERY:

This is a beautiful gel. I don't know what problem could have been mentioned on this.

KEY QUOTE
193 MR. HARMON:

If there had been a problem, could any responsible forensic scientist have rerun it?

194 MS. MONTGOMERY:

Yes. If a problem was detected, the gel should be rerun.

195 MR. HARMON:

Okay. But you saw no reason to do that in this case; is that correct?

196 MS. MONTGOMERY:

That's correct.

197 MR. HARMON:

There was a lot of discussion yesterday about terms that you've used to communicate data that you saw; a hint, a trace, possible trace. Do you recall those discussions?

198 MS. MONTGOMERY:

Yes.

199 MR. HARMON:

Do the words that you used to try to communicate or convey the data, do they somehow change the data?

200 MS. MONTGOMERY:

No, they don't.

201 MR. HARMON:

Okay. So the data is what you have shown this jury; is that correct?

202 MS. MONTGOMERY:

That's correct.

203 MR. HARMON:

And the words are words you have used to try to express that so that they can appreciate it?

204 MS. MONTGOMERY:

Correct.

205 MR. HARMON:

Mr. Blasier asked you some words about examiner bias yesterday or some questions about examiner bias. Do you recall that?

206 MS. MONTGOMERY:

Yes, I do.

207 MR. HARMON:

I want to you ask you a question about examiner bias. Can you make a 24, 25 result look like a 18 by wishful thinking?

208 MS. MONTGOMERY:

No, you can't.

209 MR. HARMON:

Did anything arise in the course of Mr. Blasier's questioning of you that in any way undermines the results that you and Mr. Sims have presented to this jury?

210 MS. MONTGOMERY:

No, there was nothing.

211 MR. HARMON:

If a responsible forensic scientist had questions about the results you have presented, could she have performed retesting to address the question scientifically?

212 MS. MONTGOMERY:

Yes. Anytime there is a question, reanalysis can be done on these samples. The ones where there were questions, reanalysis was done.

213 MR. HARMON:

And could that reanalysis be done using PCR product that you conserve?

214 MS. MONTGOMERY:

Yes.

215 MR. HARMON:

Could it be done using sample swatches that you preserve?

216 MS. MONTGOMERY:

Yes.

217 MR. HARMON:

And could it be used on extracted DNA that you preserved in this case?

218 MS. MONTGOMERY:

Yes, if any extracted DNA remains.

219 MR. HARMON:

Okay. Thanks, Miss Montgomery.

220 THE COURT:

All right. Mr. Blasier.

221 MR. BLASIER:

Thank you, your Honor.

RECROSS-EXAMINATION BY MR. BLASIER

222 MR. BLASIER:

Miss Montgomery, yesterday before lunch or at lunch I gave you every picture that I was going to use, didn't I?

223 MS. MONTGOMERY:

Yes, you did.

224 MR. BLASIER:

And I told you to look at them and compare them to your gels, didn't I?

225 MS. MONTGOMERY:

Yes, you did.

226 MR. BLASIER:

And I told you to look at them and compare to the original of your gels, not the blue film, right?

227 MS. MONTGOMERY:

I don't recall if you specifically said to compare them to the originals or the copies.

228 MR. BLASIER:

You didn't have the blue films, did you? They were in evidence?

229 MS. MONTGOMERY:

No, I have--I made multiple copies of the blue film or of the gel, both for discovery purposes and also to retain copies within--for the case files.

230 MR. BLASIER:

And I told you that I wanted you to look at them carefully to make sure that they were accurate pictures, that they accurately portrayed what you have on your film, didn't I?

231 MR. HARMON:

Objection, that is irrelevant and calls for hearsay.

232 THE COURT:

Overruled.

233 MS. MONTGOMERY:

Yes, you asked me to look at those photos and see how they compared to the--to the gels I had or the copies.

234 MR. BLASIER:

And you came back after lunch and you handed my pictures back to me and you said, "These are great, I wish we had some of these," didn't you?

235 MR. HARMON:

Your Honor, that is hearsay, we are talking about the computer; not the photo.

236 THE COURT:

Sustained.

237 MR. BLASIER:

You came back and told me "These pictures are fine," didn't you?

238 MR. HARMON:

Objection. It is irrelevant, calls for hearsay.

239 THE COURT:

Overruled. That is not irrelevant.

240 MS. MONTGOMERY:

Actually the photos, as far as showing the ladders and what the samples are and the strong band, they are excellent photos. As far as the weaker band, you need to actually see the gel to be able to capture the weaker gels and to be able to visualize them with your eyes.

241 MR. BLASIER:

Move to strike as nonresponsive.

242 THE COURT:

Overruled.

243 MR. BLASIER:

Did you tell me any of that yesterday after lunch?

244 MS. MONTGOMERY:

I told you parts of that, yes.

245 MR. BLASIER:

And I told you that for any picture that I showed if you wanted to look at your original gel you should tell me so, right?

246 MS. MONTGOMERY:

I--I don't recall if you said that or not.

247 MR. BLASIER:

Didn't I say that in front of the jury here? Do you remember that?

248 MS. MONTGOMERY:

I don't remember hearing it, but you may have said it.

249 MR. BLASIER:

And the two films that we sent--we showed to the jury, were actually your films, not my pictures, correct?

250 MS. MONTGOMERY:

That's correct.

251 MR. BLASIER:

Now, I want to show you--I want to show you 275-I which is the film with the dress samples on it, correct?

252 MR. HARMON:

Objection, it is beyond the scope.

253 THE COURT:

Overruled.

254 MS. MONTGOMERY:

Okay.

255 MR. BLASIER:

And I put a post-it on there with arrows above the two bands that you say are there at 24, correct?

256 MS. MONTGOMERY:

That's correct.

257 MR. BLASIER:

And let me show you the substrate control that Mr. Harmon asked you about which is 275-Q,. The band in the substrate control lane, have I put a post-it with an arrow above the band that you say isn't a band?

258 MR. HARMON:

Objection, it is argumentative, convoluted, compound.

259 THE COURT:

Overruled.

260 MS. MONTGOMERY:

Well, the band that you say isn't a band, it is not a band, that is why I say it isn't a band. There is the one where we were talking about it yesterday where there is this little glitch in the gel, and if we could pass it around to the jury for them to look at, that would probably help.

261 MR. BLASIER:

Do you see something there that looks like a band?

262 MS. MONTGOMERY:

No, I don't. I see an artifact in between these two lanes.

263 MR. BLASIER:

You see an artifact that looks like a band?

264 MS. MONTGOMERY:

No, it does not look like a band.

265 MR. BLASIER:

You can see something there that looks like a band and you can't see--what you can see on the dress is much fainter than what you see on the substrate control, correct?

266 MS. MONTGOMERY:

No, that is incorrect. This is not a band and it is not a band because it is not a distinct banding pattern. It also falls within two lanes, and you could tell it is just a--you know, I don't know how else to describe it besides a blip. But if you could show to it the jury, I think that would help.

267 MR. BLASIER:

Your Honor, I would like to put these on the elmo side-by-side, if we could.

268 THE COURT:

All right.

269 (Brief pause.)
270 MR. BLASIER:

Let's try one at a time. We can't fit them both on here. Let's try 275-Q, the substrate control first. Can you zoom in on it?

271 MS. MONTGOMERY:

Would it be okay if I went to the podium?

272 THE COURT:

Let's see how it projects first on the monitor.

273 MS. MONTGOMERY:

That is upside down.

274 (Discussion held off the record between the Deputy District Attorneys.)
275 MR. BLASIER:

All right. Can you see the area right below where my post-it says "No band"?

276 MS. MONTGOMERY:

Yes, I do.

277 MR. BLASIER:

That is what you are saying is not a band?

278 MS. MONTGOMERY:

That's correct.

279 MR. BLASIER:

Now, let's look at the dress. Now, you see that area?

280 MS. MONTGOMERY:

Yes, I do.

281 MR. BLASIER:

You are calling those two bands, aren't you?

282 MS. MONTGOMERY:

Excuse me.

283 MR. BLASIER:

You interpreted those at being two bands there, didn't you?

284 MS. MONTGOMERY:

Could you put it into real life instead of magnified?

285 (Brief pause.)
286 MS. MONTGOMERY:

Yes, and--as I--when I was talking or when Mr. Harmon was presenting the gels, asking me to explain some of the fainter ones, I was saying that it is difficult to see those fainter bands from when--when they are projected up on the screen and you actually have to see them. It is just like slide presentations. Sometimes you lose some of the contrast when you put something on an overhead such as this.

287 MR. BLASIER:

Your Honor, could we pass these to the jury?

288 THE COURT:

Yes.

289 MR. BLASIER:

No. 7?

290 MS. MONTGOMERY:

Mr. Blasier, I think it is best--

291 THE COURT:

There is no question pending.

292 (The exhibits were passed amongst the jurors.)
293 (Discussion held off the record between Defense counsel.)
294 MR. BLASIER:

Your Honor, could we also have a white sheet of paper? It makes it a little easier to see.

295 THE COURT:

No, they have their juror's notebooks.

296 MR. BLASIER:

Okay.

297 (Brief pause.)
298 THE COURT:

All right. Mr. Blasier, would you collect those items from Deputy Russell.

299 (Brief pause.)
300 THE COURT:

All right. Thank you, counsel. Proceed.

301 MR. BLASIER:

Miss Montgomery, these slides we just showed the jury, this is what you submitted to the Court as evidence of your testing, correct?

302 MS. MONTGOMERY:

Do those have the evidence labels on them?

303 MR. BLASIER:

I'm sorry?

304 MS. MONTGOMERY:

Yes.

305 MR. BLASIER:

Do they have the labels?

306 MS. MONTGOMERY:

Yes, yes, those are the two.

307 MR. BLASIER:

Now, cross-hybridization, I want to ask you a couple of questions about what Mr. Harmon asked you. Under what conditions do you get cross-hybridization so that you have a 1.3 dot show up?

308 MS. MONTGOMERY:

Cross-hybridization can occur when there is a slight difference in the temperature of the stringency wash during the typing process of the DQ-Alpha. And I believe Dr. Cotton may have gone into this in a bit more detail, and if the temperature is slightly off, then you could get some of this weak dot, some of the weak dots occurring within the sample.

309 MR. BLASIER:

There are controls built into the system so that you don't have temperatures too low, correct?

310 MS. MONTGOMERY:

Well, we use--we calibrate our water bath and we check it with a thermometer, but sometimes if the water level is not high enough, then you could have a high subtle--or a slight difference in the temperature from between where the strips are and to--where the water level ends and then where the top of the tray is.

311 MR. BLASIER:

What does the amplitype user's guys says with respect to cross-hybridization and when it can occur in terms of how much you have to test?

312 MS. MONTGOMERY:

The user's manual--actually if I could refer to that.

313 MR. BLASIER:

Let me refer you to section 6.2.3.

314 MS. MONTGOMERY:

Yes. They talk about cross-hybridization and how it can occur when too much--when you develop your strips for too long or too much DNA is added into the--too much DNA is amplified and these are two other ways that cross-hybridization can occur.

315 MR. BLASIER:

Does the manual say that it can occur when you develop your pictures properly and don't use too much DNA?

316 MS. MONTGOMERY:

When you develop your pictures properly?

317 MR. BLASIER:

Well, let's talk about one of those at a time?

318 MS. MONTGOMERY:

If that is a question.

319 MR. BLASIER:

I'm sorry. If you use the appropriate quantity of DNA you shouldn't get that, right?

320 MS. MONTGOMERY:

No, that is not what this says.

321 MR. BLASIER:

Well, why don't you read it to us.

322 MS. MONTGOMERY:

Would you like me to read the whole paragraph to you.

323 MR. BLASIER:

Yes, yes.

324 MS. MONTGOMERY:

Okay. It is section 6.2.3 of the amplitype user's guide put out by Roche. There is a Cetus emblem because Cetus was the original company and it was bought out by Roche. And in the supporting material section 6-5, it talks about typing of large amounts of amplified DNA. It is a long paragraph.

325 MR. BLASIER:

Go ahead.

326 MS. MONTGOMERY:

"Amplification of samples containing high level of starting DNA," parenthetically, "Greater than 30 nanograms, generally results in large quantities of amplified DNA. Hybridization of very high concentrations of amplified DNA to the probe strips can sometimes lead to the detection of faint background signals much weaker than the C dot which is due to nonspecific, quote, `cross-hybridization' unquote. Cross-hybridization in this context refers to the weak interaction of a probe with a DQ-Alpha sequence allele that is not perfectly complimentary. This occurs more with the subtyping probes than with the typing probes because the subtyping probes detect differences between the alleles of only one or two bases." That is only halfway through. "The extent of cross-hybridization, even with very high levels of amplified DNA, is so low that any faint background signals only appear after lengthy color development. These nonspecific signals do not appear if the color development reaction is stopped with a degree of coloration of the specific dots appears to have reached a maximum."

327 MR. BLASIER:

You can stop there if you like, unless you want to read the rest.

328 MS. MONTGOMERY:

Yeah, I think we should read the rest.

329 MR. BLASIER:

Okay.

330 MS. MONTGOMERY:

"Some samples having very large quantities of amplified DNA require only five to ten minutes for maximum coloration." And our laboratory we develop between 20 and 30 minutes. "Development of color beyond this point, overdevelopment, can also lead to high strip background which decreases contrast." And that is one thing our laboratory--Dr. Blake has noted that we should stop our color development a little earlier than we do.

331 MR. BLASIER:

Mr. Harmon told you to use Dr. Blake's name as many times as you could, didn't he?

KEY QUOTE
332 MS. MONTGOMERY:

He did not tell me to use Dr. Blake's name as many times.

333 MR. BLASIER:

No, he didn't? So the manual tells you that you shouldn't get these dots if you develop your film the appropriate amount of time, doesn't it?

334 MS. MONTGOMERY:

Well, it is in the film. What we are talking about are strips and those are the membranes, the thin membranes that have the dots on them, the 1 dot, the 2 dot, the 3 dot, so we are referring to strips, not film.

335 MR. BLASIER:

The manual says that you only get that phenomena when you develop it for too long, correct?

336 MS. MONTGOMERY:

The manual says that is one reason why you can get that.

337 MR. BLASIER:

And it also says you have to have a high molecular weight of DNA before you see that phenomena, too, right?

338 MS. MONTGOMERY:

No. It said that a high level of DNA and that is one way that cross-hybridization can occur.

339 MR. BLASIER:

High level means a lot of DNA, doesn't it?

340 MS. MONTGOMERY:

Yes, it does.

341 MR. BLASIER:

And in the mixed samples in this case you had very low level of DNA, didn't you?

342 MS. MONTGOMERY:

That's correct.

343 MR. BLASIER:

Now, does it describe any other way you get cross-hybridization in here, other than those two ways?

344 MS. MONTGOMERY:

Not in that particular manual.

345 MR. BLASIER:

And this is put out by the manufacturer of the kit?

346 MS. MONTGOMERY:

That's correct.

347 (Discussion held off the record between Defense counsel.)
348 MR. BLASIER:

Now, Dr. Blake's paper on case work analysis, would you agree that that says that you don't get cross-hybridization unless the temperature is too low; 54 degrees rather than 55?

349 MS. MONTGOMERY:

Yes. I believe what the article is referring to is the 1992 publication by Dr. Blake and some other individual states that with changes in the temperature that cross-hybridization can occur.

350 MR. BLASIER:

Now, let's assume hypothetically that you can get cross-hybridization at lower levels of DNA. Would you agree that what that results in giving you is 1.3 dots that really aren't there? I'm sorry, that don't represent any DNA?

351 MS. MONTGOMERY:

Well, I think we need to remember that these dots are very faint and they are not interpreted as part of the--the results. These 1.3's are outlines or hints. If it is anything substantial, and there is a question, then reanalysis should be conducted.

352 MR. BLASIER:

So these are the hints as opposed to the possible traces?

353 MS. MONTGOMERY:

Well, you are bringing possible trace into the way the D1S80 is described. There--the hint as opposed to a trace. If it is trace, then you want to reexamine those samples.

354 MR. BLASIER:

Now, when you got--when you have a trace, you want to reexamine them?

355 MS. MONTGOMERY:

Yes. One should reexamine, if there is a trace amount.

356 (Brief pause.)
357 MR. BLASIER:

Let me show you Defense 1172-A on the elmo.

358 MR. BLASIER:

You recall, Miss Montgomery, that this is the second time that you ran these proficiency samples, correct?

359 (No audible response.)
360 MR. BLASIER:

I'm sorry, that is the first time?

361 MS. MONTGOMERY:

Yes, that is the first analysis.

362 MR. BLASIER:

And you got one hint and one trace and you got a hint in QC 839 and a trace in the positive control, correct?

363 MS. MONTGOMERY:

That's correct.

364 MR. BLASIER:

So you did it again. Would that be the reason why you did it again?

365 MS. MONTGOMERY:

No, I don't believe that is the reason why I did it again. I would need to see that whole case file to determine why subsequent analysis was done on this sample.

366 MR. BLASIER:

All right. And you got nothing in your evidence sample, the actual proficiency sample, of any hints or traces, did you?

367 MS. MONTGOMERY:

That's correct.

368 MR. BLASIER:

Now, let me show you also 1172-B?

369 THE COURT:

Why don't you pull the microphone closer.

370 (Witness complies.)
371 MR. BLASIER:

This is the second time you ran those same samples, isn't it?

372 MS. MONTGOMERY:

That's correct.

373 MR. BLASIER:

And you got two traces in your proficiency evidence samples, did you not--actually, you got three, didn't you?

374 MS. MONTGOMERY:

Yes, that's true, but if you look at the control on that strip, the positive control, and the QC sample, there is nothing indicated there. And as far as the type that was reported out for these samples, umm--let's see, I can't--on sample 433, the reported result is a 1.2, 3. Those trace amounts in the--the trace amounts of cross-hybridization were not reported out. They weren't significant to the analysis.

375 MR. BLASIER:

You characterize them as a trace when you read the dots, didn't you?

376 MS. MONTGOMERY:

Yes, that is what I wrote.

377 MR. BLASIER:

And you didn't redo that, did you?

378 MS. MONTGOMERY:

No, I did not.

379 MR. BLASIER:

And your quality control showed--I think you just indicated the quality controlled worked fine. That shows two hints, doesn't it?

380 MS. MONTGOMERY:

Yes. Those are hints or just a small amount of color developing in those.

381 MR. BLASIER:

And this is the proficiency test that you say you got the right answers?

382 MS. MONTGOMERY:

Yes, I did.

383 MR. BLASIER:

Could we have the glove board, please?

384 THE COURT:

Yes. Boards.

385 MR. BLASIER:

Well, actually maybe I can do without that. May we have 1173-C, please.

386 (Brief pause.)
387 MR. BLASIER:

Miss Montgomery, yesterday when I showed you this, I asked you whether the stains G10, G11 and G13 were in the wrist area, didn't I?

388 MS. MONTGOMERY:

I believe you did, yes.

389 MR. BLASIER:

You said they were?

390 MS. MONTGOMERY:

Yes. They are in the lower portion of the glove.

391 MR. BLASIER:

In the wrist area, aren't they?

392 MS. MONTGOMERY:

I believe that is correct.

393 MR. BLASIER:

So where I have circled is the wrist area, isn't it?

394 MS. MONTGOMERY:

Well, yes, that is the lower level of the glove. One would call it a wrist area.

395 MR. BLASIER:

Okay. Now, the upper area of the glove, is it accurate to say that the various samples that were tested, that Mr. Simpson was excluded from any bloodstains on that glove up around the finger area where someone might grab the fingers to take the glove off?

396 MS. MONTGOMERY:

Yes. There were areas in the finger region that were tested and there was no 25 allele detected in those samples.

397 MR. BLASIER:

And there was no--Mr. Simpson was excluded from any sample in the palm area where someone's finger might make contact if they were holding it with the other hand?

398 MR. HARMON:

Assumes, facts not in evidence, that they were all tested, your Honor.

399 THE COURT:

Sustained.

400 MR. BLASIER:

You tested a large number of samples from that glove, didn't you?

401 MR. HARMON:

Objection. That is vague.

402 THE COURT:

Overruled.

403 MS. MONTGOMERY:

Gary Sims examined the glove and I guess I should--I should note that for G11 it was near the wrist notch, it was termed the outside palmer surface. And as I stated, Mr. Sims looked at all these samples and extracted them and then I analyzed them for D1S80.

404 MR. BLASIER:

The reason for taking so many samples was to get a representative sample from different parts of the glove, correct?

405 MS. MONTGOMERY:

That--that would be one reason to test various areas, yes.

406 MR. BLASIER:

And various areas were tested and Mr. Simpson was excluded from everywhere on that glove except the wrist area, correct?

KEY QUOTE
407 MS. MONTGOMERY:

Well, as I stated, the wrist and near the wrist area.

408 MR. BLASIER:

Miss Montgomery, have you ever taken a pair of leather gloves off by pulling them off at the wrist?

409 MR. HARMON:

Objection. That is irrelevant.

410 THE COURT:

Sustained.

411 MR. BLASIER:

I have no further questions.

412 THE COURT:

Mr. Harmon.

413 MR. HARMON:

Can we keep that up there for a second?

414 (Brief pause.)
415 (Discussion held off the record between the Deputy District Attorneys.)
416 MR. HARMON:

We will come back to that in a second.

417 (Discussion held off the record between the Deputy District Attorneys.)
418 MR. HARMON:

I just have a couple questions, Miss Montgomery.

FURTHER REDIRECT EXAMINATION BY MR. HARMON

419 MR. HARMON:

The cross-hybridization, when you were reading from the user guide there was something in there that I think need to be clarified. I believe the exact words were that this cross-hybridization occurs more with the subtyping probes?

420 MS. MONTGOMERY:

Yes, that's correct.

421 MR. HARMON:

Could you tell the jury, just so they understand what that means, what are the subtyping probes that were used in this case?

422 MS. MONTGOMERY:

Well, the sub--subtyping probes, there are four nominal alleles, and this is the 1 allele, the 2 allele, the 3 allele and the 4 allele and then there are also subtypes and that is the 1.1 and the 1.3 and the 1.2, but the 1.2 has to be inferred because there is not a specific probe for that 1.2. So it is more common to see the cross-hybridization occurring with samples of the subtype.

423 (Discussion held off the record between the Deputy District Attorneys.)
424 MR. HARMON:

Can we show 1173-C. Could you come back here, Miss Montgomery.

425 (Witness complies.)
426 MR. HARMON:

Okay. What I would like to--what I would like you to do is just so the jury can appreciate what this means and doesn't mean, you know the symbol for circle with a line through?

427 MS. MONTGOMERY:

Yes.

428 MR. HARMON:

Could you put that over the "No genotypes consistent with O.J.S.," please.

429 (Witness complies.)
430 MR. HARMON:

And maybe we need--

431 MS. MONTGOMERY:

Whoops, wrong way. Is that what you would like?

432 MR. HARMON:

Yes. Let's make this line as thin as possible because they are kind of beefy there. Down below "Genotypes consistent with Defendant" if you can fit that in there.

433 (Witness complies.)
434 MR. HARMON:

Or just "Types consistent with Defendant."

435 MS. MONTGOMERY:

(Witness complies.) this is like one of those boards.

436 MR. HARMON:

Does that make you dizzy?

437 MS. MONTGOMERY:

It is very difficult to write here.

438 (Brief pause.)
439 MS. MONTGOMERY:

How does John Madden do this?

KEY QUOTE
440 (Brief pause.)
441 MS. MONTGOMERY:

Can you read that?

442 MR. HARMON:

We will remember what that means. Could we capture that, your Honor, and I don't know if that is 1173-C(1) or I'm not sure how we number this one.

443 THE COURT:

This one would be a Prosecution exhibit.

444 MR. HARMON:

Okay. Okay. Miss Montgomery, we are done with that now.

445 THE CLERK:

276.

446 THE COURT:

276.

447 (Peo's 276 for id = photograph)
448 MR. HARMON:

Could I have 275-C back up there? And this is my last few questions.

449 (Brief pause.)
450 (Discussion held off the record between the Deputy District Attorneys.)
451 MR. HARMON:

Miss Montgomery, while--this is the substrate control, the 50C, I'm pretty sure that is the one it is--or no, that's the--I'm sorry. The gel that had the other control on it, 275-Q.

452 (Discussion held off the record between the Deputy District Attorneys.)
453 MR. HARMON:

Now, we just need to get back to a little basics here. You put the samples in all the way across the top and they move in one direction; is that right?

454 MS. MONTGOMERY:

That's correct.

455 MR. HARMON:

I believe one of the things you said is that whatever that is, it is not a band; is that right?

456 MS. MONTGOMERY:

That's correct.

457 MR. HARMON:

One of the reasons it is not a band is that it is not in a lane; is that true?

458 MS. MONTGOMERY:

Right. That is one of the reasons. I think you will want to clear the telestrator. Yes, and it doesn't have the definition of a band.

459 MR. HARMON:

Well, let's just focus on where it is. It is your opinion that it is not in one of those lanes; is that right?

460 MS. MONTGOMERY:

That's correct.

461 MR. BLASIER:

Objection, leading.

462 THE COURT:

Overruled.

463 MR. HARMON:

Now, can--these bands, they are DNA, they are started out--they are DNA material, right?

464 MS. MONTGOMERY:

Correct.

465 MR. HARMON:

I think we heard amplicons. There is amplicons in there?

466 MS. MONTGOMERY:

Correct.

467 THE COURT:

Pull the microphone closer, please.

468 (Witness complies.)
469 MR. HARMON:

Now, can these things move sideways?

470 MS. MONTGOMERY:

No. They are moving down through the gel.

471 MR. HARMON:

I mean, suppose it was a band full of amplicons from a very willful person. Could they--and they wanted to turn left. Could they do that?

KEY QUOTE
472 MS. MONTGOMERY:

No, they do not have control over themselves.

473 MR. HARMON:

They move in one direction?

474 MS. MONTGOMERY:

That's correct.

475 MR. HARMON:

And one direction only?

476 MS. MONTGOMERY:

Correct.

477 MR. HARMON:

Thanks. No further questions, your Honor.

478 THE COURT:

Mr. Blasier.

479 MR. BLASIER:

No further questions.

480 THE COURT:

All right. Miss Montgomery, thank you very much. You are excused. All right. Let me see counsel without the court reporter, please.

Temperature

procedural

Key Quotes (5)

Ms. Montgomery
This is a beautiful gel. I don't know what problem could have been mentioned on this.
Spontaneous defense of her work product when asked about a gel Blasier had previously criticized — undercuts the defense's implied quality-control narrative.
Robert Blasier
Mr. Harmon told you to use Dr. Blake's name as many times as you could, didn't he?
Attempts to undermine Montgomery's redirect testimony by implying coaching, after she repeatedly cited Dr. Blake's published work to legitimize her methods.
Ms. Montgomery
Various areas were tested and Mr. Simpson was excluded from everywhere on that glove except the wrist area, correct? ... Well, as I stated, the wrist and near the wrist area.
Key concession establishing that Simpson's DNA profile appeared only at the wrist/notch of the Rockingham glove — the area someone would grip when removing a glove from another person.
Ms. Montgomery
How does John Madden do this?
Spontaneous humor while struggling to write on the courtroom telestrator board, breaking tension during a dense technical proceeding.
Rockne Harmon
I mean, suppose it was a band full of amplicons from a very willful person. Could they--and they wanted to turn left. Could they do that?
Lighthearted closing question to establish that DNA bands can only move in one direction through a gel, thereby undercutting any suggestion that the disputed artifact was a misidentified band.

Evidence (10)

Defense 1173-C
Defense graphic showing locations of stains on the Rockingham glove that produced the 25 allele
Discussed and marked up by Montgomery with the prosecution — annotated with 'no genotypes consistent with OJS' and 'types consistent with defendant' symbols; became People's 276
People's 272-A and 272-B
Photo boards of the Rockingham right-hand glove (item no. 9)
Used by Montgomery to physically point out stain locations G10, G11, and G13 to the jury
People's 275-C
Gel showing typing results for Bundy stain no. 50 (24, 25 result)
Projected to confirm no bands appeared in the hypothetical artifact region
People's 275-Q
Gel showing substrate control with disputed artifact between lanes
Passed to jury during recross; central to dispute over whether artifact was a real band
People's 275-I
Film with dress sample results showing 24 allele bands
Shown during recross for side-by-side comparison with substrate control artifact
Defense 1172-A
First run of proficiency test showing one hint and one trace
Discussed during recross to question why a second run was performed
+ 4 more

Notable Exchanges (4)

Robert BlasierMs. Montgomery
Blasier revealed that he had given Montgomery all his photos before lunch and asked her to verify their accuracy against the original gels. He then attempted to introduce her pre-testimony statement — 'These are great, I wish we had some of these' — to show she had endorsed the photo quality. Montgomery acknowledged the photos were good for strong bands but insisted originals were needed for weaker bands.
strategic
Robert BlasierMs. Montgomery
Blasier walked Montgomery through section 6.2.3 of the Amplitype user guide, which she read aloud in full. The manual specified cross-hybridization only occurs with high levels of DNA or overdevelopment — conditions Blasier argued were absent in the low-DNA mixed samples in this case. Montgomery conceded the mixed samples had 'very low level of DNA.'
revealing
Robert BlasierMs. Montgomery
Blasier established that OJ Simpson was excluded from all tested stain areas on the Rockingham glove except the wrist and near-wrist region (G10, G11, G13), including finger areas and palm areas. He then asked whether Montgomery had ever removed leather gloves by pulling at the wrist — objection sustained before she could answer.
strategic
Rockne HarmonMs. Montgomery
Harmon constructed an extended hypothetical ('imaginary band') to show that even if the disputed substrate control artifact were a real band, it would not have matched the 24, 25 result from Bundy stain no. 50. Judge Ito sustained multiple objections to the word 'imaginary' as argumentative, requiring repeated rephrasing.
strategic

Light Moments (3)

Lance A. Ito
After Harmon admitted his computer expert 'whispered in his ear' to correct his misstatement about how the gel photos were displayed, Judge Ito deadpanned: 'Whispered in your ear.'
Ms. Montgomery
While struggling to write annotations on the courtroom telestrator board, Montgomery spontaneously asked: 'How does John Madden do this?'
Rockne Harmon
Harmon closed his redirect by asking whether amplicons could move sideways 'if they were from a very willful person and wanted to turn left.' Montgomery replied: 'No, they do not have control over themselves.'

Credibility Attacks (3)

⚔ Ms. Montgomery
prior inconsistent statement / coaching implication
Blasier attempted to introduce Montgomery's pre-testimony statement that his computer scan photos were 'great' or 'fine,' contradicting her redirect testimony that scan photos were insufficient to detect weaker bands. He also asked whether Harmon had instructed her to invoke Dr. Blake's name as often as possible, implying coached testimony.
⚔ Ms. Montgomery
cross-examination on manufacturer standards
Blasier used the Amplitype user guide to argue that the conditions under which cross-hybridization occurs (high DNA quantity, overdevelopment) were not present in this case's low-DNA mixed samples, undermining Montgomery's explanation for the proficiency test anomalies.
⚔ Ms. Montgomery
bias / examiner bias challenge
Harmon preemptively addressed Blasier's prior day questioning on examiner bias by asking Montgomery directly whether wishful thinking could change a 24, 25 result into an 18 — she said no. Blasier's recross implicitly revisited this by highlighting traces and hints that were not re-run.

Witness Demeanor

(Witness complies.) [multiple instances of Montgomery adjusting microphone or moving to podium as directed]
Spontaneous and conversational — volunteered opinions, occasionally offered to read full passages aloud, showed mild frustration at the telestrator board
Firm and consistent in defending artifact interpretation even when Blasier pressed visually with jury-passed gels

Objections

16 objections (9 sustained, 7 overruled)
Proceeding 6168 • 480 utterances • Prosecution witness
Criminal Trial
Department 103
⚖️ Start
📂 MAY 24, 1995 📄 Redirect examination of Renee
MAY 24, 1995 KRT DvH TD